Overview of Acebrophylline Capsules:
UNOBRO-OD Sustained Release Tablets contains Acebrophylline which has an advantage of once daily administration. It has inherent benefits in terms of patient compliance. Acebrophylline was found to be superior to theophylline in efficacy and tolerability in patients with mild bronchial asthma and mild persistent asthma.
Trypsin and Bromelain belongs to the class of naturally occuring systemic enzymes and Rutoside Trihydrate is a phytonutrient. Diclofenac belongs to the class of non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions.
OBETRA-D Tablets can be used in the treatment of following conditions:
- Post-operative pain.
- Edema and inflammation in contusions, lacerations, cuts, sinusitis, otitis, externa, PID (Pelvic inflammatory disease), tooth extraction, cellulitis, abscess, sport injuries, sprains and surgery.
- Painful osteoarthritis, rheumatoid arthritis, spondylopathies, tendonitis, polymyositis, dermatomyositis and gout.
- Pain management of kidney stones and gallstones, chronic pain in cancer, post-traumatic pain, dysmenorrhea and acute migraines.
- Temporary relief from aches, pains and muscle soreness due to everyday activity.
One OBETRA-D Tablet three times a day or as directed by Physician.
Trypsin and Bromelain are proteolytic enzymes. They break peptide bond inside protein molecules. Bromelain exerts anti-inflammatory activity by affecting prostaglandin synthesis. Rutoside is a glycoside and has antioxidant effect. It increases the strength of the walls of the blood capillaries and regulates their permeability. Diclofenac inhibit both leukocyte migration and the enzyme cylooxygenase (COX-1 and COX-2), leading to the peripheral inhibition of prostaglandin synthesis.